📰 Nasdaq Tech News
Page 8 - Nasdaq Tech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Tech. Real-time updates on events, politics, business and more.
June 6, 2023
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) have been given a consensus rating of “Moderate Buy” by the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month […]
June 6, 2023
Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Risk & Volatility Bio-Techne has a beta of 1.26, meaning that its […]
June 3, 2023
Quadrant Capital Group LLC grew its position in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 267.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,556 shares of the biotechnology company’s stock after purchasing an additional 1,132 shares during the quarter. Quadrant Capital […]
May 30, 2023
Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Risk & Volatility Bio-Techne has a beta of 1.25, suggesting that its […]
May 26, 2023
Simplify Asset Management Inc. lifted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 335.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,524 shares of the biotechnology company’s stock after purchasing an additional 3,484 shares […]
May 22, 2023
StockNews.com initiated coverage on shares of Bio-Techne (NASDAQ:TECH – Get Rating) in a research note published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the stock. Robert W. Baird raised their price target on shares of Bio-Techne from […]
May 22, 2023
Sandhill Capital Partners LLC raised its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 291.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 468,346 shares of the biotechnology company’s stock after purchasing an additional 348,675 shares during the period. Bio-Techne accounts […]
May 21, 2023
Sit Investment Associates Inc. boosted its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,700 shares of the biotechnology company’s stock after buying an additional 35,025 shares during the period. Sit Investment […]
May 21, 2023
Sit Investment Associates Inc. lifted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 46,700 shares of the biotechnology company’s stock after buying an additional 35,025 shares during the quarter. Sit […]
May 21, 2023
Lord Abbett & CO. LLC raised its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 330.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 332,452 shares of the biotechnology company’s stock after purchasing an additional 255,192 shares during the period. Lord Abbett & CO. LLC’s holdings in Bio-Techne were worth $27,553,000 as […]